Skip to content

Utilizing In Vivo and Imaginal Exposure in the Context of MDMA-Assisted Therapy for Social Anxiety Disorder: A Case Report

Jason B. Luoma, M. Kati Lear, Kyong Yi, Brian Pilecki

preprint DOI: 10.31234/osf.io/wft35_v1 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case report Randomized
Sample size 1
Population Man in his late 30s with generalized social anxiety disorder
Interventions MDMA-assisted therapy imaginal exposure in vivo exposure imagery rescripting social activation homework
Duration Three non-drug preparation sessions, two drug sessions, and six non-drug integration sessions
Topics Anxiety MDMA
Key findings MDMA-assisted therapy incorporating imaginal and in vivo exposure techniques led to significant reduction in social anxiety symptoms and functional impairment in a participant with generalized SAD.

Abstract

This case report describes the application of in vivo and imaginal exposure techniqueswithin MDMA-assisted therapy (MDMA-AT) for social anxiety disorder (SAD). The treatment,conducted as part of a randomized controlled trial, consisted of three non-drug preparationsessions, two drug sessions, and six non-drug integration sessions. Exposure interventionsincluded imaginal exposure to shame-related memories during MDMA sessions, in vivo socialexposures during MDMA sessions, imagery rescripting exercises during integration sessions, andsocial activation homework between sessions. The participant, a man in his late 30s withgeneralized SAD, showed significant reduction in symptoms and functional impairment asmeasured by the Leibowitz Social Anxiety Scale and Sheehan Disability Scale. Qualitativereports indicated increased social engagement, reduced anxiety in social situations, and a shifttowards more self-compassion. The participant found both imaginal and in vivo exposuresduring MDMA sessions particularly impactful, reporting they allowed him to access intrinsicdesires for social connection and performance that were previously masked by anxiety. This casesuggests MDMA-AT incorporating exposure techniques may be a promising treatment for SAD,warranting further research.